Table 2 Operative characteristics of patients undergoing tricuspid valve surgery for isolated rheumatic tricuspid regurgitation (n = 26). Data are Presented as Mean ± SD, Median (Range), or n (%)

Median sternotomy

24 (92.3%)

14 (100%)

10 (83.3%)

Right thoracotomy

2 (7.7%)

0 (0%)

2 (16.7%)

Beating heart

9 (34.6%)

2 (14.3%)

7 (58.3%)

Cardioplegia

17 (65.4%)

12 (85.7%)

5 (41.7%)

- Cold crystalloid St Thomas cardioplegia

9 (52.9%)

7 (77.8%)

2 (22.2%)

- Cold blood high potassium cardioplegia

8 (47.1%)

5 (35.7%)

3 (25%)

Cardio-pulmonary bypass time (minute)

95.4 ± 39.7

87.9 ± 19.7

104.1 ± 54.4

Cross aortic clamping time (minute)

60 (35–170)

60 (38–170)

52 (35–103)

Hemofiltration (n, %)

6 (23.1%)

4 (28.6%)

2 (16.7%)

 Mean ± SD (ml/Kg)

78.7 ± 34.6

89.7 ± 16.4

56.8 ± 16.2

Difficult weaning from cardio-pulmonary bypass

9 (34.6%)

3 (21.4%)

6 (50%)

Tricuspid valve repair:

15 (57.7%)

13 (92.9%)

2 (16.7%)

- Carpentier Edwards ring n°30

1 (3.8%)

1 (7.1%)

0 (0%)

- Carpentier Edwards ring n°32

11 (42.3%)

9 (64.3%)

2 (16.7%)

- Carpentier Edwards ring n°34

3 (11.5%)

3 (21.4%)

0 (0%)

Tricuspid valve replacement:

11 (42.3%)

1 (7.1%)

10 (83.3%)

- Mechanical prosthesis:

6 (23.1%)

0 (0%)

6 (50%)

- SJM n°27

1 (3.8%)

0 (0%)

1 (8.3)

- Sorin Bicarbon n°27

1 (3.8%)

0 (0%)

1 (8.3)

- ATS n°29

2 (7.7%)

0 (0%)

2 (16.7%)

- ATS n°31

1 (3.8%)

0 (0%)

1 (8.3)

- Carbomedics Valve n°31

1 (3.8%)

0 (0%)

1 (8.3)

- Biological prosthesis:

5 (19.2%)

1 (7.1%)

4 (33.3%)

- Sorin Pericarbon More n°27

1 (3.8%)

0 (0%)

1 (8.3%)

- SJM Epic Biocor Valve n°27

1 (3.8%)

0 (0%)

1 (8.3%)

- Medtronic Hancock Tissue Valve II n°29

2 (7.7%)

1 (7.1%)

1 (8.3%)

- SJM Epic Biocor Valve n°31

1 (3.8%)

0 (0%)

1 (8.3%)